Studies have shown an average weight loss of 15% of body weight over 26-30 weeks, especially for people with a BMI of 30 or higher, or those with a BMI of 27 or higher and obesity-related health issues like type 2 diabetes
Of course, many questions remain unanswered
Conducted among both healthy individuals and patients with type 2 diabetes, the MGH trial showed that GLP-1 (7-37) had potent insulinotropic effects in both groups
Information about data access request proposals can be found at Change history 28 May 2024 In the version of the article initially published, in Fig
Pure Impact, using advanced PlyoPulse technology, forms part of our integrated approach for patients on GLP-1 therapy who wish to protect muscle while achieving fat loss
Here are strategies that can help quiet the noise and reclaim your mental space, no matter your body or goals